Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors
Clinical trial NCT01562626 · SUSPENDED
Trial details
- NCT number
- NCT01562626
- Sponsor
- Anaeropharma Science, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2021-05-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.